1. India Stocks

  2. •

    Basic Materials

  3. •

    Chemicals - Specialty
Rossari Biotech Limited

Rossari Biotech Limited

ROSSARI.BO
Rossari Biotech LimitedIN flagBombay Stock Exchange
529.65
INR
-15.40
- -
29.34BMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
60.21
106.02
123.03
137.19
268.96
299.62
330.59
376.16
432.82
385.71
Basic EPS, GAAP
5.25
9.44
13.42
15.56
17.81
19.46
23.67
24.66
26.95
24.41
Free Cash Flow per Basic Share
2.41
5.62
-3.94
-2
-1.62
21.53
-15.94
-3.81
-36.05
- -
Dividend per Share
0.05
2.19
0.54
0.49
0.5
0.5
0.5
0.5
0.5
- -
Book Value per Share
14.77
22.36
35.18
48.31
62.5
81.21
104.25
128.07
2
- -
Tangible Book Value per Share
17.98
24.35
57.98
76.68
99.3
116.22
142.16
170.09
200.38
- -
Basic Weighted Avg Shares
48
48
49
52
55
55
55
55
55
55
Sales/Revenue/Turnover
2,914
5,131
5,982
7,074
14,752
16,513
18,252
20,803
23,964
21,344
Operating Margin (%)
12.89
12.79
14.73
14.17
8.82
9.18
10.01
9.52
8.63
9.3
Depreciation Expense
52
123
169
228
481
629
604
671
791
694
Net Income, GAAP
254
457
653
802
977
1,073
1,307
1,364
1,492
1,351
Effective Tax Rate (%)
32.21
27.94
25.71
25.08
28.31
25.63
26.42
26.36
26.32
26.71
Profit Margin (%)
8.72
8.9
10.91
11.34
6.62
6.5
7.16
6.56
6.23
6.33
Working Capital
367
380
1,776
2,045
3,146
3,717
4,188
5,054
4,463
- -
LT Debt
13
7
340
- -
- -
349
442
1,223
1,146
- -
Total Equity
871
1,238
2,867
4,088
8,052
9,152
10,477
11,854
13,333
- -
Return on Invested Capital (%)
- -
39.57
26.78
19.52
15.11
12.39
12.41
11.31
9.56
- -
Return on Capital (%)
- -
46.55
38.72
33.93
35.56
28.38
23.84
18.45
24.79
107.53
Return on Common Equity (%)
- -
50.85
46.73
38.18
33
27.14
25.55
21.25
41.49
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
957
- -
LT Borrowings
- -
1,000
- -
LT Finance Leases
- -
223
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
55
- -
Market Capitalization
42,814
33,406
38,154

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
10,419
- -
Cash, Cash Equivalents & STI
- -
1,165
- -
Accounts Receivable, Net
- -
4,745
- -
Inventories
- -
3,551
- -
Total Current Liabilities
- -
5,366
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
957
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
30.15%
12.48%
Free Cash Flow
- -
-171.08%
847.38%
Net Income, GAAP
- -
13.44%
9.41%
Sales/Revenue/Turnover
- -
32.03%
15.19%
Total Cash Common Dividend
- -
- -
0.11%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4,106
4,835
4,638
4,673
18,252
2025
4,896
4,984
5,127
5,796
20,803
2026
5,437
5,817
6,849
- -
23,964

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5.3
5.97
6.23
- -
23.67
2025
6.32
6.39
5.73
6.22
24.66
2026
6.07
5.92
8.3
- -
26.95

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.5
2025
- -
- -
- -
- -
0.5
2026
- -
- -
- -
- -
0.5

Company Description

APIChat
CEO
Edward Walter Menezes
Full Time Employees
450
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
201 A & B, Akruti Corporate Park Mumbai India 400078
IPO Date
Jul 23, 2020
Website
rossari.com
Similar Companies
Lanxess AG (LNXSY)
Ami Organics Limited (AMIORG.NS)
AirBoss of America Corp. (BOS.TO)
Fuchs Petrolub SE (FUPBY)
WD-40 Company (WDFC)
Polyram Plastic Industries Ltd. (POLP.TA)
Business
Rossari Biotech Limited manufactures and markets specialty chemicals, enzymes, and biotech solutions primarily for the textile, animal health and nutrition, home and personal care, and performance chemicals sectors. The company offers a diversified portfolio including textile specialty chemicals such as enzymes and products for pre-treatment, dyeing, printing, and finishing; animal health products encompassing poultry feed supplements, additives, vitamin premixes, enzymes, acidifiers, trace minerals, essential oils, and pet-care solutions; home and personal care formulations featuring laundry and cleaning enhancers; and performance chemicals like polymers for detergents, emulsions for paints and paper, ceramics strengtheners, and water treatment agents. Rossari Biotech Limited operates manufacturing facilities in India, including sites in Dahej, Silvassa, and through subsidiaries, with a primary focus on the Indian market and emerging global expansion; founded in 2003 as Rossari Labtech and incorporated in 2009, the company maintains headquarters in Mumbai, Maharashtra. Recent developments include capacity expansions such as an additional 20,000 MTPA at its Dahej facility, 15,000 MTPA ethoxylation at Unitop Chemicals (Phase 1), and further enhancements at Tristar Intermediates and Unitop totaling over 50,000 MTPA; acquisitions of Unitop Chemicals Private Limited, Tristar Intermediates Private Limited, Romakk Chemicals Private Limited, and Lozalo International for pet-care; land purchases adjoining Dahej for Rs 15 crore and in Gujarat for Rs 9 crore by subsidiaries; and approval of up to USD 8 million investment in a wholly-owned subsidiary in Saudi Arabia to bolster international presence.